Stock 300841 CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chengdu Kanghua Biological Products Co., Ltd.

Equities

300841

CNE100003Y57

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
59.68 CNY +4.72% Intraday chart for Chengdu Kanghua Biological Products Co., Ltd. +6.31% -23.03%
Apr. 23 Chengdu Kanghua Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on January 23, 2024. CI

Business Summary

Chengdu Kanghua Biological Products Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of vaccine products. The Company's main products are Rabies Vaccine (human diploid cell) for Human Use, Freeze-dried and Group ACYW135 Meningococcal Polysaccharide Vaccine. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 672

Sales per Business

CNY in Million2022Weight2023Weight Delta
Non-immune Planning Vaccine
100.0 %
- - 1,577 100.0 % -
Veterinary Vaccine
0.0 %
4 0.3 % 0 0.0 % -87.85%
Others
0.0 %
0 0.0 % 0 0.0 % -99.30%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.9 %
1,446 99.9 % 1,575 99.9 % +8.97%
Overseas
0.1 %
1 0.1 % 2 0.1 % +157.94%

Managers

Managers TitleAgeSince
Qing Han Wang CEO
 Chief Executive Officer 50 17-04-30
Wen Nian Wu DFI
 Director of Finance/CFO 41 10-05-31
Wen Li Hou BRD
 Director/Board Member 41 17-04-30
Hao Lu IRO
 Public Communications Contact 39 21-07-15

Members of the board

Members of the board TitleAgeSince
Xiao Bo Fang BRD
 Director/Board Member 50 20-02-29
Zhen Tao Wang CHM
 Chairman 58 -
Xiong Ping Yu BRD
 Director/Board Member 48 17-04-30
Bing Hui Zhang BRD
 Director/Board Member 61 18-07-15
Hai Ying Tao BRD
 Director/Board Member 50 21-07-15
Qing Han Wang CEO
 Chief Executive Officer 50 17-04-30
Wen Li Hou BRD
 Director/Board Member 41 17-04-30
Shu Qing Wu CHM
 Chairman 37 18-07-15
Xiao Wen Li BRD
 Director/Board Member 39 -
Qiang Wei Zhang BRD
 Director/Board Member 35 21-05-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 134,650,449 85,462,788 ( 63.47 %) 901,775 ( 0.6697 %) 63.47 %

Shareholders

NameEquities%Valuation
Zhong Geng Fund Management Co. , Ltd.
13.98 %
12,791,437 13.98 % 98 M ¥
Yingke Innovation Asset Management Co. Ltd.
13.70 %
12,538,692 13.70 % 96 M ¥
Zhong Ou Asset Management Co., Ltd
11.81 %
10,808,215 11.81 % 83 M ¥
Yong Cai
7.308 %
6,687,422 7.308 % 51 M ¥
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
0.9855 %
901,775 0.9855 % 7 M ¥
Cinda Fund Management Co. Ltd.
0.4295 %
393,000 0.4295 % 3 M ¥
Rongtong Fund Management Co., Ltd.
0.3283 %
300,450 0.3283 % 2 M ¥
Fiera Capital (UK) Ltd.
0.2661 %
243,500 0.2661 % 2 M ¥
Bosera Asset Management Co., Ltd.
0.2233 %
204,300 0.2233 % 2 M ¥
GF Fund Management Co., Ltd.
0.2212 %
202,425 0.2212 % 2 M ¥
NameEquities%Valuation
Zhen Tao Wang
70.26 %
30,310,155 70.26 % 233 M ¥
Qing Han Wang
2.980 %
1,285,678 2.980 % 10 M ¥
Sheng You Li
0.8086 %
348,848 0.8086 % 3 M ¥
Huai Gong Chen
0.5007 %
215,993 0.5007 % 2 M ¥
Ming Tai Tang
0.5007 %
215,992 0.5007 % 2 M ¥
Wen Nian Wu
0.3940 %
169,982 0.3940 % 1 M ¥
Wen Li Hou
0.3004 %
129,595 0.3004 % 995 525 ¥
Wan Feng Sun
0.3004 %
129,595 0.3004 % 995 525 ¥
Xiao Wen Li
0.0904 %
38,985 0.0904 % 299 476 ¥

Holdings

NameEquities%Valuation
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD.
0.99%
 901,775 0.99% 6,927,273 $

Company contact information

Chengdu Kanghua Biological Products Co., Ltd.

182 Beijing Road Economic & Technological Dev Zone

610100, Chengdu

+

http://www.kangh.com
address Chengdu Kanghua Biological Products Co., Ltd.(300841)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Chengdu Kanghua Biological Products Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
59.68 CNY
Average target price
102 CNY
Spread / Average Target
+70.93%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD. Stock Chengdu Kanghua Biological Products Co., Ltd.
-23.03% 1.1B
CSL LIMITED Stock CSL Limited
-2.86% 87.31B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.95% 40.86B
BIOGEN INC. Stock Biogen Inc.
-21.94% 29.36B
UCB Stock UCB
+56.21% 24.49B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-5.41% 17.31B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.23% 11.26B
INCYTE CORPORATION Stock Incyte Corporation
-17.60% 11.62B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-13.96% 11.31B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.92% 8.31B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 300841 Stock
  4. Company Chengdu Kanghua Biological Products Co., Ltd.